Clinical and molecular characterization of HER2 amplified-pancreatic cancer

BACKGROUND: Pancreatic cancer is one of the most lethal and molecularly diverse malignancies. Repurposing of therapeutics that target specific molecular mechanisms in different disease types offers potential for rapid improvements in outcome. Although HER2 amplification occurs in pancreatic cancer,...

Descrición completa

Gardado en:
Detalles Bibliográficos
Main Authors: Chou, Angela, Waddell, Nicola, Cowley, Mark J, Gill, Anthony J, Chang, David K, Patch, Ann-Marie, Nones, Katia, Wu, Jianmin, Pinese, Mark, Johns, Amber L, Miller, David K, Kassahn, Karin S, Nagrial, Adnan M, Wasan, Harpreet, Goldstein, David, Toon, Christopher W, Chin, Venessa, Chantrill, Lorraine, Humphris, Jeremy, Mead, R Scott, Rooman, Ilse, Samra, Jaswinder S, Pajic, Marina, Musgrove, Elizabeth A, Pearson, John V, Morey, Adrienne L, Grimmond, Sean M, Biankin, Andrew V
Formato: Artigo
Idioma:Inglês
Publicado: BioMed Central 2013
Assuntos:
Research
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC3978667/
https://ncbi.nlm.nih.gov/pubmed/24004612
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/gm482
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares